SCHEMBL13865334

SCHEMBL13865334

CO[C@H](CCO)C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.67
KDM4E B2RXH2 1/20 0.67
ALDH1A1 P00352 1/20 0.67
MEN1 O00255 6/20 0.65
KMT2A Q03164 6/20 0.65
POLB P06746 4/20 0.65
SCN3A Q9NY46 2/20 0.60
SCN1A P35498 1/20 0.60
SCN4A P35499 1/20 0.60
SCN5A Q14524 1/20 0.60
SCN9A Q15858 1/20 0.60
SCN2A Q99250 1/20 0.60
SCN8A Q9UQD0 1/20 0.60
SCN10A Q9Y5Y9 1/20 0.60
PKM P14618 2/20 0.58
LMNA P02545 1/20 0.57
TSHR P16473 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL826283 0.86 ALDH1A1 (0.84) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL183941 0.85 SCN3A (0.60) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL826391 0.85 SCN3A (0.60) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL183942 0.85 SCN3A (0.60) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL15113161 0.81 TDP1 (1.00) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL13651636 0.80 ALDH1A1 (0.84) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL10031619 0.80 ALDH1A1 (0.84) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL1091645 0.79 TDP1 (0.73) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL1102252 0.78 KMT2A (1.00) TDP1KDM4EALDH1A1MEN1KMT2A
SCHEMBL1101958 0.77 MEN1 (0.75) TDP1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064747-A2 4(-3-(-2-(PHENYL)MORPHOLINO)-2-OXOPYRROLIDIN-1-YL)-N-(THIAZOL-2-YL)BENZENESULFONAMIDE DERIVATI VES AND RELATED COMPOUNDS AS MODULATORS OF ION CHANNELS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-05-22 WO disclosed